cephalosporin c has been researched along with creatine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Madsen, PO; Naber, KG; Westenfelder, SR | 1 |
Aronoff, GR; Blase, DK; Connors, BA; Evan, AP; Gattone, VH; Luft, FC | 1 |
Bundtzen, RW; Craig, WA; Madsen, PO; Nielson, OS; Toothaker, RD; Welling, PG | 1 |
Bush, K; Drusano, GL; Kahn, JB; Kimko, HC; Lodise, TP; Murthy, BP; Noel, GJ; Pypstra, R | 1 |
4 other study(ies) available for cephalosporin c and creatine
Article | Year |
---|---|
Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.
Topics: Acetamides; Cephalosporins; Creatine; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Inulin; Iodine Isotopes; Iothalamic Acid; Kidney; Kidney Function Tests; Methods; Nitriles; Urinary Tract Infections | 1974 |
Effects of moxalactam and cefotaxime on rabbit renal tissue.
Topics: Acetylglucosaminidase; Animals; Cefotaxime; Cephalosporins; Cephamycins; Creatine; Kidney; Kidney Glomerulus; Male; Moxalactam; Rabbits | 1982 |
Pharmacokinetics of cefuroxime in normal and impaired renal function: comparison of high-pressure liquid chromatography and microbiological assays.
Topics: Adult; Biological Assay; Cefuroxime; Cephalosporins; Chromatography, High Pressure Liquid; Creatine; Humans; Kidney Diseases; Kinetics; Male | 1981 |
Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clinical Trials, Phase II as Topic; Computer Simulation; Creatine; Drug Administration Schedule; Drug Therapy, Computer-Assisted; Female; Gram-Negative Bacteria; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Population; Probability; Staphylococcus; Treatment Outcome | 2007 |